Shannon focuses her practice on healthcare regulatory matters with a specific emphasis in the specialty pharmacy industry. She advises clients on regulatory matters arising in pharmaceutical trade and distribution, such as the Anti-Kickback Statute, the Health Insurance Portability and Accountability Act (HIPAA), the Civil Monetary Penalty Law, and FDA regulations such as the Drug Supply Chain Security Act. Additionally, she assists clients with the development, drafting and negotiation of agreements related to various components of the drug supply chain, such as limited distribution networks, pharmacy services agreements, and hub arrangements. Shannon also provides regulatory guidance on transactional issues.
American Health Lawyers Association (AHLA)
Tennessee Bar Association
Memphis Bar Association — Board Member of the Health Law Section (2015, 2016), CLE Committee Chair (2015, 2016)
Represented Fred’s, Inc. in its sale of EntrustRx to CVS Health Corporation.
Represented Medical Specialties Distributors (MSD) to McKesson Corporation.
Represented a leading provider of 340B Drug Pricing Program services in its acquisition by a prescription benefit management subsidiary of a leading pharmacy healthcare provider
Represented Frazier Healthcare Partners in its acquisition of a specialty pharmacy platform
Assisted a biopharmaceutical manufacturer with a limited distribution network oncology drug launch
Represented Modern HC Holdings, Inc. in its sale to The Kroger Company
Represented Avita Drugs Inc. in its sale to Long’s Drugs Inc.
Provided regulatory counsel to Cardinal Health Specialty Solutions in its acquisition of RainTree Oncology Services
Mid-South Super Lawyers “Rising Star” (2013-2018)
Cecil C. Humphreys Law Review